Literature DB >> 17085289

Anaphylactic and anaphylactoid causes of angioedema.

Paul A Greenberger1.   

Abstract

Anaphylactic and anaphylactoid (pseudoallergic) reactions can be expected to occur with greater frequency as the number of immunomodulators are employed. The immune system will become sensitized to these new therapeutic agents or there may be first-dose reactions depending on the pathogenetic mechanism involved. Physicians should review their office or procedure room emergency preparedness protocols and medications. The lack of penicillin major and minor determinants for penicillin testing has made management of penicillin and cephalosporin allergic patients more complicated. In the absence of skin-testing materials, test-challenges will be necessary and performed with less comfort because of not knowing the current level of immunologic sensitization to penicillin. The indication for readministration of any incriminated medication/therapeutic agent should be reviewed. Often, there are not suitable alternatives. Various approaches have been presented to permit safer readministration of essential medications or diagnostic agents to prevent episodes of anaphylaxis or upper airway angioedema.

Entities:  

Mesh:

Year:  2006        PMID: 17085289     DOI: 10.1016/j.iac.2006.09.002

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  5 in total

1.  Hyperelastic modeling of swelling in fibrous soft tissue with application to tracheal angioedema.

Authors:  Kun Gou; Thomas J Pence
Journal:  J Math Biol       Date:  2015-05-21       Impact factor: 2.259

Review 2.  Recurrent angioedema and the threat of asphyxiation.

Authors:  Konrad Bork
Journal:  Dtsch Arztebl Int       Date:  2010-06-11       Impact factor: 5.594

Review 3.  Angioedema with normal laboratory values: the next step.

Authors:  Janelle Sher; Mark Davis-Lorton
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

4.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

5.  Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema.

Authors:  Jonathan A Bernstein; Joseph Moellman
Journal:  Int J Emerg Med       Date:  2012-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.